These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8827400)

  • 1. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
    Schneider NG; Lunell E; Olmstead RE; Fagerström KO
    Clin Pharmacokinet; 1996 Jul; 31(1):65-80. PubMed ID: 8827400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.
    Schneider NG; Olmstead RE; Franzon MA; Lunell E
    Clin Pharmacokinet; 2001; 40(9):661-84. PubMed ID: 11605715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Lancaster T
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL; Zevin S; Jacob P
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2004; (3):CD000146. PubMed ID: 15266423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine replacement therapy.
    Fant RV; Owen LL; Henningfield JE
    Prim Care; 1999 Sep; 26(3):633-52. PubMed ID: 10436291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2002; (4):CD000146. PubMed ID: 12519537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.
    Sweeney CT; Fant RV; Fagerstrom KO; McGovern JF; Henningfield JE
    CNS Drugs; 2001; 15(6):453-67. PubMed ID: 11524024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
    Gourlay SG; Benowitz NL
    Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.
    Walele T; Sharma G; Savioz R; Martin C; Williams J
    Regul Toxicol Pharmacol; 2016 Feb; 74():187-92. PubMed ID: 26696273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threshold doses for nicotine discrimination in smokers and non-smokers.
    Perkins KA; Fonte C; Sanders M; Meeker J; Wilson A
    Psychopharmacology (Berl); 2001 May; 155(2):163-70. PubMed ID: 11401005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
    Bullen C; McRobbie H; Thornley S; Glover M; Lin R; Laugesen M
    Tob Control; 2010 Apr; 19(2):98-103. PubMed ID: 20378585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.
    Benowitz NL; Zevin S; Jacob P
    J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal nicotine spray: a rapid nicotine delivery system.
    Sutherland G; Russell MA; Stapleton J; Feyerabend C; Ferno O
    Psychopharmacology (Berl); 1992; 108(4):512-8. PubMed ID: 1410168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.